Back to search
Pediatric Recurrent Progressive Low-grade Gliomas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Recurrent Progressive Low-grade Gliomas trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Recurrent Progressive Low-grade Gliomas trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study aims to evaluate the efficacy of Laser Interstitial Thermal Therapy (LITT) in treating recurrent or progressive, low-grade gliomas (LGG) in pediatric…
This is a Pilot, multicenter, open-label study of patients less than or equal to 25 years, with recurrent or progressive LGG harboring a CRAF or BRAF alteration…
This is a Phase 2, multi center, open-label study to evaluate the safety and efficacy of Type II RAF (tovorafenib) in pediatric participants with low-grade glio…
This is an open label study of everolimus in children with recurrent or progressive low-grade glioma.
The phase 1b study is aimed at determining the pediatric recommended phase 2 dose (RP2D) of Infigratinib. The phase 2 study will evaluate efficacy and safety o…